Ittai Dev Disposes 33,320 MDB Shares via Pre-Set Trading Plan
Rhea-AI Filing Summary
Insider stock sales by MongoDB CEO and director Ittai (Ittycheria) Dev on 08/28/2025 totaled 33,320 Class A shares sold under a Rule 10b5-1 plan. The filings list multiple block sales at weighted-average prices from about $297.83 up to $310.17, with per-tranche price ranges disclosed in footnotes. Following these disposals, the reporting person beneficially owned 203,237 Class A shares. The Form 4 was signed by an attorney-in-fact on 09/02/2025 and confirms the trades were made pursuant to a pre-established trading plan rather than ad hoc transactions.
Positive
- Transactions executed under a Rule 10b5-1 plan, indicating pre-established trading instructions
- Detailed price ranges and weighted-average prices provided for transparency
- Timely Form 4 filing signed by attorney-in-fact on 09/02/2025
Negative
- Insider sold 33,320 Class A shares, reducing beneficial ownership to 203,237 shares
Insights
TL;DR: CEO/director sold 33,320 Class A shares via a Rule 10b5-1 plan, leaving 203,237 shares held.
The reported transactions are routine executive liquidity under a documented Rule 10b5-1 plan, reducing beneficial ownership from earlier levels to 203,237 Class A shares. Sales occurred in multiple tranches at weighted-average prices reported per tranche between $297.83 and $310.17, with detailed price ranges disclosed in footnotes. There is no indication in this Form 4 of options exercised, purchases, or derivative transactions—only non-derivative sales. For investors, this filing documents insider selling but attributes it to a pre-established plan, which typically reduces the likelihood the trades reflect new private information.
TL;DR: Sales executed under a 10b5-1 plan, signed by attorney-in-fact; procedural compliance appears met.
The Form 4 identifies the reporting person as both President & CEO and a director, and explicitly checks the box indicating the transactions were executed pursuant to a Rule 10b5-1 trading plan. The filing includes weighted-average prices and per-tranche ranges for transparency and is signed by an attorney-in-fact on 09/02/2025. From a governance perspective, use of a documented 10b5-1 plan and timely disclosure aligns with standard insider-trading compliance practices. The filing does not present material corporate governance concerns by itself.